The scientific interface between a life-sciences company and the clinical community — deliberately separated from commercial, and increasingly the function that determines whether a product's evidence is understood, funded and used. This page covers what medical affairs owns, what governs it, and the systems the work runs on.
Discuss Your Use CaseMedical affairs manages the scientific conversations that commercial teams cannot have, giving clinicians accurate, non-promotional answers to evidence questions.
The function has grown from a support role into a strategic one, for three reasons:
Payers, health technology assessment bodies and clinical guideline committees ask questions that registration trials were not designed to answer. Closing those gaps is evidence work, and evidence work sits in medical.
Access to promotional interaction has narrowed while interest in substantive scientific exchange has not. In many therapy areas the medical science liaison now holds the more durable relationship.
Medical affairs is measured over years and damaged in single conversations. That shapes how the function operates — cautiously, with documentation, and with a strong preference for being accurate over being fast.
Field-based scientists engaging clinicians, investigators and opinion leaders non-promotionally. They discuss data, gather clinical insight, support investigator-initiated research and identify evidence gaps. They do not sell, and their objectives are not commercial.
Handling unsolicited questions about a product from clinicians, pharmacists and sometimes patients. Responses draw on approved standard response documents, or are researched and prepared where none exists. Every request and response is recorded, and recurring questions are a signal in their own right.
Publication planning, manuscript and abstract development, congress materials, and the scientific platform defining how a product's evidence is communicated. Governed by authorship and transparency standards.
Identifying, mapping and engaging clinical opinion leaders, advisory boards, guideline committees and professional societies — with strict documentation of purpose, fair-market-value payment and permitted topics.
Real-world evidence studies, registries, investigator-initiated studies, health-economic modelling and outcomes research. Designed to answer the questions registration trials left open.
Participation in the review of externally facing content, holding the scientific accuracy position within MLR.
Structured capture of what the field is hearing — clinical questions, unmet needs, competitor evidence and practice patterns — and routing it to the teams that can act without breaching the commercial boundary.
Global
Medical affairs activity must be genuinely scientific in purpose, content and measurement. Commercial objectives cannot be assigned to medical roles.
Global
Separate reporting lines, separate systems, controlled data sharing, and defined rules on what field insight may pass to commercial.
US and most markets
Off-label information may be provided only in response to a genuine unsolicited question, documented as such.
US
The basis on which truthful, non-misleading scientific information may be shared outside promotional constraints.
Global
Payments to healthcare professionals for advisory or research work must be documented, justified and reportable.
US, EU, others
Disclosure of transfers of value including advisory fees, honoraria, travel and research support.
Global publications
Who may be named as an author, and disclosure of funding, medical writing support and conflicts.
Global
Standards for company-sponsored publication development, including transparency of sponsorship.
Global
Any adverse event mentioned during a medical interaction must be captured and reported within defined timelines.
Global research
Applicable where medical affairs sponsors or supports interventional research.
EU / US
Lawful basis and consent for holding clinician and patient data used in engagement and evidence work.
The recurring operational requirement: everything is recorded. Who was engaged, on what topic, at whose initiation, with what materials, and whether any safety information arose. Medical affairs systems are documentation systems before they are anything else.
Inbound request intake across phone, email and web, case handling, response library and recurrence reporting.
The controlled library of approved scientific answers, version-managed with review dates.
Engagement planning, interaction records, insight capture and access to scientific content in the field.
Profiles, engagement history, publications, affiliations, advisory participation and payment records.
Manuscript and abstract pipelines, congress calendars, authorship and disclosure tracking.
EDC, registries and real-world data environments supporting medical-led research.
The destination for any adverse event captured during a medical interaction.
The medical position within MLR, with reviewer records per asset version.
Systematic tracking of published evidence relevant to the product and therapy area.
BUILD WITH CONFIDENCE
Nirmitee Health builds medical information, insight and evidence software for medical affairs teams. Healthcare is the only industry we serve.